Wave Life Sciences Ltd.
WVE
NASDAQ·Healthcare·Biotechnology·Mkt cap $957.7M
$4.86
▲ +3.40%
P/E
-4.46
Mkt Cap
$957.7M
52-Wk Range
$4.65–$21.73
52-Week Range
$4.65 - $21.73
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 35.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
3 reasons
- Proprietary PRISM platform for stereopure oligonucleotide discovery and optimization
- Strategic partnerships with Pfizer, Takeda, and leading academic research institutions
- Differentiated approach to RNA-targeting therapeutics with improved stereochemistry and efficacy
Bear Case
1 risk
- Low volatility (beta -1.3).
Growth
Revenue decline expected
Advancement of clinical-stage programs toward regulatory milestones and potential approvals
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Weak
-14.7% over 3m
Quality
Excellent
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying WVE right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
JUL 30, 2026
Reported EPS of -$0.34 vs -$0.30 consensus (-13.4% surprise). Revenue of $2.3M vs $7.4M expected (-69.5%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-13.4%
Revenue trend · last 8Q
—
+188%
-27%
-56%
+199%
-79%
+317%
-74%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
-$7.7M
$83.7M
$9.2M
$8.7M
$7.6M
$17.2M
$38.2M
$2.3M
Margins · last 8Q
Gross
—
Operating
—
Profit
-3052.6%
Wall Street consensus
8 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: B. Riley · Jul 31, 2026
vs Industry
How WVE stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related